{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:40:51Z","timestamp":1792604451565,"version":"4.5.0"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.bmc.2025.118093","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T08:59:06Z","timestamp":1738227546000},"page":"118093","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Identification and optimization of a small molecule inhibitor of the ovarian tumor protease of the Crimean-Congo hemorrhagic fever virus"],"prefix":"10.1016","volume":"120","author":[{"given":"Lorenz","family":"Beckmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Liessmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maik","family":"Icker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic","family":"Rieger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip","family":"Schlegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Urban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Meiler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara T.","family":"Schoeder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maik","family":"Tretbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2025.118093_b0005","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.antiviral.2004.08.001","article-title":"Crimean-Congo hemorrhagic fever","volume":"64","author":"Whitehouse","year":"2004","journal-title":"Antiviral Res"},{"key":"10.1016\/j.bmc.2025.118093_b0010","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S1473-3099(06)70435-2","article-title":"Crimean-Congo haemorrhagic fever","volume":"6","author":"Erg\u00f6n\u00fcl","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.bmc.2025.118093_b0015","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.antiviral.2013.07.006","article-title":"Crimean-Congo hemorrhagic fever: history, epidemiology, pathogenesis, clinical syndrome and genetic diversity","volume":"100","author":"Bente","year":"2013","journal-title":"Antiviral Res"},{"key":"10.1016\/j.bmc.2025.118093_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.cimid.2020.101429","article-title":"New aspects about Crimean-Congo hemorrhagic fever (CCHF) cases and associated fatality trends: A global systematic review and meta-analysis","volume":"69","author":"Nasirian","year":"2020","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"10.1016\/j.bmc.2025.118093_b0025","doi-asserted-by":"crossref","unstructured":"A.R. Garrison, S.V. Alkhovsky A\u043b\u044cxo\u0432c\u043a\u0438\u0439 Cep\u0433e\u0439 B\u043ba\u0434\u0438\u043c\u0438po\u0432\u0438\u0447, T. Av\u0161i\u010d-\u017dupanc, D.A. Bente, \u00c9. Bergeron, F. Burt, N. Di Paola, K. Erg\u00fcnay, R. Hewson, J.H. Kuhn, A. Mirazimi, A. Papa \u0386\u03bd\u03bd\u03b1 \u03a0\u03b1\u03c0\u03ac, A.A. Sall, J.R. Spengler, G. Palacios, I.R. Consortium, ICTV Virus Taxonomy Profile: Nairoviridae J Gen Virol 101 2020 798 799 10.1099\/jgv.0.001485.","DOI":"10.1099\/jgv.0.001485"},{"key":"10.1016\/j.bmc.2025.118093_b0030","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41579-023-00871-9","article-title":"Crimean-Congo haemorrhagic fever virus","volume":"21","author":"Hawman","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.bmc.2025.118093_b0035","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1017\/S0950268809990367","article-title":"Assessing the impact of climate change on vector-borne viruses in the EU through the elicitation of expert opinion","volume":"138","author":"Gale","year":"2010","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.bmc.2025.118093_b0040","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms9091907","article-title":"Crimean-Congo Hemorrhagic Fever Virus in Asia, Africa and Europe","volume":"9","author":"Shahhosseini","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.bmc.2025.118093_b0045","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s40475-021-00235-4","article-title":"Crimean-congo hemorrhagic fever virus (CCHFV): a silent but widespread threat","volume":"8","author":"Kuehnert","year":"2021","journal-title":"Curr Trop Med Rep"},{"key":"10.1016\/j.bmc.2025.118093_b0050","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.virol.2003.09.042","article-title":"Crimean-Congo hemorrhagic fever virus genome L RNA segment and encoded protein","volume":"321","author":"Honig","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.bmc.2025.118093_b0055","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.virol.2003.09.046","article-title":"Sequence determination of the Crimean-Congo hemorrhagic fever virus L segment","volume":"321","author":"Kinsella","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.bmc.2025.118093_b0060","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1128\/JVI.03252-12","article-title":"Diversity of ubiquitin and ISG15 specificity among nairoviruses' viral ovarian tumor domain proteases","volume":"87","author":"Capodagli","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.bmc.2025.118093_b0065","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.chom.2007.09.014","article-title":"Ovarian tumor domain-containing viral proteases evade ubiquitin- and ISG15-dependent innate immune responses","volume":"2","author":"Frias-Staheli","year":"2007","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.bmc.2025.118093_b0070","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1128\/JVI.06277-11","article-title":"Arterivirus and nairovirus ovarian tumor domain-containing Deubiquitinases target activated RIG-I to control innate immune signaling","volume":"86","author":"van Kasteren","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.bmc.2025.118093_b0075","doi-asserted-by":"crossref","first-page":"10219","DOI":"10.1128\/JVI.01643-15","article-title":"RIG-I Mediates an Antiviral Response to Crimean-Congo Hemorrhagic Fever Virus","volume":"89","author":"Spengler","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.bmc.2025.118093_b0080","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1016\/j.celrep.2017.08.040","article-title":"Crimean-congo hemorrhagic fever virus suppresses innate immune responses via a ubiquitin and ISG15 specific protease","volume":"20","author":"Scholte","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.bmc.2025.118093_b0085","first-page":"662","article-title":"Host and viral modulation of RIG-I-mediated antiviral immunity","volume":"7","author":"Liu","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.bmc.2025.118093_b0090","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/nature05732","article-title":"TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity","volume":"446","author":"Gack","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2025.118093_b0095","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/imr.13022","article-title":"The molecular mechanism of RIG-I activation and signaling","volume":"304","author":"Thoresen","year":"2021","journal-title":"Immunol Rev"},{"key":"10.1016\/j.bmc.2025.118093_b0100","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/s41579-018-0020-5","article-title":"ISG15 in antiviral immunity and beyond","volume":"16","author":"Perng","year":"2018","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.bmc.2025.118093_b0105","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.1016\/j.jmb.2019.03.013","article-title":"ISG15: It's Complicated","volume":"431","author":"Dzimianski","year":"2019","journal-title":"J Mol Biol"},{"key":"10.1016\/j.bmc.2025.118093_b0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008610","article-title":"ISG15 overexpression compensates the defect of Crimean-Congo hemorrhagic fever virus polymerase bearing a protease-inactive ovarian tumor domain","volume":"14","author":"Devignot","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.bmc.2025.118093_b0115","doi-asserted-by":"crossref","DOI":"10.3390\/v13071195","article-title":"Crimean-congo hemorrhagic fever virus: current advances and future prospects of antiviral strategies","volume":"13","author":"Dai","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.bmc.2025.118093_b0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006372","article-title":"Potent and selective inhibition of pathogenic viruses by engineered ubiquitin variants","volume":"13","author":"Zhang","year":"2017","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.bmc.2025.118093_b0125","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01065-19","article-title":"Stable occupancy of the crimean-congo hemorrhagic fever virus-encoded deubiquitinase blocks viral infection","volume":"10","author":"Scholte","year":"2019","journal-title":"mBio"},{"key":"10.1016\/j.bmc.2025.118093_b0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008283","article-title":"Independent inhibition of the polymerase and deubiquitinase activities of the Crimean-Congo Hemorrhagic Fever Virus full-length L-protein","volume":"14","author":"Tchesnokov","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.bmc.2025.118093_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2024.199398","article-title":"Evaluation of two inoculation routes of an adenovirus-mediated viral protein inhibitor in a Crimean-Congo hemorrhagic fever mouse model","volume":"345","author":"Scholte","year":"2024","journal-title":"Virus Res"},{"key":"10.1016\/j.bmc.2025.118093_b0140","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s11262-015-1226-5","article-title":"Fluorometric CCHFV OTU protease assay with potent inhibitors","volume":"51","author":"Kocabas","year":"2015","journal-title":"Virus Genes"},{"key":"10.1016\/j.bmc.2025.118093_b0145","first-page":"239","article-title":"Identification of small molecule binding pocket for inhibition of Crimean\u2013Congo hemorrhagic fever virus OTU protease, Turk","volume":"40","author":"Kocaba\u015f","year":"2016","journal-title":"J Biol"},{"key":"10.1016\/j.bmc.2025.118093_b0150","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202202448","article-title":"Virtual screening, molecular docking, molecular dynamics and ADMET studies on the OTU protease of crimean\u2010congo hemorrhagic fever virus","volume":"7","author":"Yildirim","year":"2022","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.bmc.2025.118093_b0155","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature24451","article-title":"Molecular basis of USP7 inhibition by selective small-molecule inhibitors","volume":"550","author":"Turnbull","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2025.118093_b0160","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nature09299","article-title":"Enhancement of proteasome activity by a small-molecule inhibitor of USP14","volume":"467","author":"Lee","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2025.118093_b0165","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/s41422-018-0091-x","article-title":"Small molecule inhibitors reveal allosteric regulation of USP14 via steric blockade","volume":"28","author":"Wang","year":"2018","journal-title":"Cell Res"},{"key":"10.1016\/j.bmc.2025.118093_b0170","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1021\/acs.jmedchem.2c01933","article-title":"Discovery and characterization of BAY-805, a potent and selective inhibitor of ubiquitin-specific protease USP21","volume":"66","author":"G\u00f6ricke","year":"2023","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118093_b0175","doi-asserted-by":"crossref","first-page":"12020","DOI":"10.1021\/jacs.0c04527","article-title":"Discovery of a potent and selective covalent inhibitor and activity-based probe for the deubiquitylating enzyme UCHL1, with antifibrotic activity","volume":"142","author":"Panyain","year":"2020","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmc.2025.118093_b0180","doi-asserted-by":"crossref","first-page":"13645","DOI":"10.1021\/acs.jmedchem.2c00408","article-title":"Discovery of potent OTUB1\/USP8 dual inhibitors targeting proteostasis in non-small-cell lung cancer","volume":"65","author":"Tan","year":"2022","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118093_b0185","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/s41419-023-05900-2","article-title":"Discovery of an OTUD3 inhibitor for the treatment of non-small cell lung cancer","volume":"14","author":"Zhang","year":"2023","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.bmc.2025.118093_b0190","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/s41467-023-36246-0","article-title":"Accelerating inhibitor discovery for deubiquitinating enzymes","volume":"14","author":"Chan","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.bmc.2025.118093_b0195","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrd.2017.152","article-title":"Deubiquitylating enzymes and drug discovery: emerging opportunities","volume":"17","author":"Harrigan","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bmc.2025.118093_b0200","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1303072","article-title":"The emerging role and therapeutic implications of bacterial and parasitic deubiquitinating enzymes","volume":"14","author":"Wehrmann","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.bmc.2025.118093_b0205","doi-asserted-by":"crossref","first-page":"10710","DOI":"10.1021\/acs.jmedchem.4c00230","article-title":"Structure-Based Design and Synthesis of Covalent Inhibitors for Deubiquitinase and Acetyltransferase ChlaDUB1 of Chlamydia trachomatis","volume":"67","author":"Zimmermann","year":"2024","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118093_b0210","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.molcel.2021.10.027","article-title":"Deubiquitinases: From mechanisms to their inhibition by small molecules","volume":"82","author":"Lange","year":"2022","journal-title":"Mol Cell"},{"key":"10.1016\/j.bmc.2025.118093_b0215","first-page":"1758","article-title":"Identification and validation of selective deubiquitinase inhibitors, Cell","volume":"28","author":"Varca","year":"2021","journal-title":"Chem Biol"},{"key":"10.1016\/j.bmc.2025.118093_b0220","doi-asserted-by":"crossref","first-page":"4496","DOI":"10.1021\/acs.jmedchem.3c01661","article-title":"Covalent Fragment Screening and Optimization Identifies the Chloroacetohydrazide Scaffold as Inhibitors for Ubiquitin C-terminal Hydrolase L1","volume":"67","author":"Imhoff","year":"2024","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118093_b0225","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s11030-009-9187-z","article-title":"Design of chemical libraries with potentially bioactive molecules applying a maximum common substructure concept","volume":"14","author":"Lisurek","year":"2010","journal-title":"Mol Divers"},{"key":"10.1016\/j.bmc.2025.118093_b0230","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ab.2007.07.034","article-title":"A sensitive fluorescence intensity assay for deubiquitinating proteases using ubiquitin-rhodamine110-glycine as substrate","volume":"371","author":"Hassiepen","year":"2007","journal-title":"Anal Biochem"},{"key":"10.1016\/j.bmc.2025.118093_b0235","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1021\/ja0455547","article-title":"ALARM NMR: a rapid and robust experimental method to detect reactive false positives in biochemical screens","volume":"127","author":"Huth","year":"2005","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmc.2025.118093_b0240","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1021\/jm901137j","article-title":"New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays","volume":"53","author":"Baell","year":"2010","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118093_b0245","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/s41573-022-00542-z","article-title":"Advances in covalent drug discovery","volume":"21","author":"Boike","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bmc.2025.118093_b0250","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1023\/A:1008354229396","article-title":"Identification of compounds with binding affinity to proteins via magnetization transfer from bulk water","volume":"18","author":"Dalvit","year":"2000","journal-title":"J Biomol NMR"},{"key":"10.1016\/j.bmc.2025.118093_b0255","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1021\/ja01318a057","article-title":"Some Derivatives of Benzoyl and Furoyl Isothiocyanates and their Use in Synthesizing Heterocyclic Compounds 1","volume":"56","author":"Douglass","year":"1934","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmc.2025.118093_b0260","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bmc.2025.118093_b0265","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1021\/acs.jmedchem.8b01766","article-title":"2-Aminothiazole Derivatives as Selective Allosteric Modulators of the Protein Kinase CK2. 1. Identification of an Allosteric Binding Site","volume":"62","author":"Bestgen","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118093_b0270","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1002\/adsc.201400941","article-title":"Copper(II)\u2010Catalyzed Single\u2010Step Synthesis of Aryl Thiols from Aryl Halides and 1,2\u2010Ethanedithiol","volume":"357","author":"Liu","year":"2015","journal-title":"Adv Synth Catal"},{"key":"10.1016\/j.bmc.2025.118093_b0275","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/slct.201600028","article-title":"Oxidation of thiols to sulphonic acids with Oxone \u00ae \/NaHCO 3 and KBrO 3","volume":"1","author":"Parida","year":"2016","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.bmc.2025.118093_b0280","doi-asserted-by":"crossref","first-page":"4139","DOI":"10.1021\/jo00067a058","article-title":"Dialkyltin oxide mediated addition of trimethylsilyl azide to nitriles. A novel preparation of 5-substituted tetrazols","volume":"58","author":"Wittenberger","year":"1993","journal-title":"J Org Chem"},{"key":"10.1016\/j.bmc.2025.118093_b0285","doi-asserted-by":"crossref","first-page":"7255","DOI":"10.1002\/ange.201003733","article-title":"Synthesis of 5\u2010Substituted 1 H \u2010Tetrazoles from Nitriles and Hydrazoic Acid by Using a Safe and Scalable High\u2010Temperature Microreactor Approach","volume":"122","author":"Gutmann","year":"2010","journal-title":"Angew Chem"},{"key":"10.1016\/j.bmc.2025.118093_b0290","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1152\/physrev.00002.2013","article-title":"Deubiquitylases from genes to organism","volume":"93","author":"Clague","year":"2013","journal-title":"Physiol Rev"},{"key":"10.1016\/j.bmc.2025.118093_b0295","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007515","article-title":"Probing the impact of nairovirus genomic diversity on viral ovarian tumor domain protease (vOTU) structure and deubiquitinase activity","volume":"15","author":"Dzimianski","year":"2019","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.bmc.2025.118093_b0300","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0226415","article-title":"Determining the molecular drivers of species-specific interferon-stimulated gene product 15 interactions with nairovirus ovarian tumor domain proteases","volume":"14","author":"Dzimianski","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.bmc.2025.118093_b0305","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1128\/JVI.02496-10","article-title":"Structural analysis of a viral ovarian tumor domain protease from the Crimean-Congo hemorrhagic fever virus in complex with covalently bonded ubiquitin","volume":"85","author":"Capodagli","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.bmc.2025.118093_b0310","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1515\/bchm3.1992.373.2.393","article-title":"Oxyanion hole interactions in serine and cysteine proteases","volume":"373","author":"M\u00e9nard","year":"1992","journal-title":"Bio Chem Hoppe-Seyler"},{"key":"10.1016\/j.bmc.2025.118093_b0315","doi-asserted-by":"crossref","first-page":"6391","DOI":"10.1021\/jo100651s","article-title":"On catalytic preorganization in oxyanion holes: highlighting the problems with the gas-phase modeling of oxyanion holes and illustrating the need for complete enzyme models","volume":"75","author":"Kamerlin","year":"2010","journal-title":"J Org Chem"},{"key":"10.1016\/j.bmc.2025.118093_b0320","doi-asserted-by":"crossref","first-page":"5938","DOI":"10.1021\/acs.jcim.2c01073","article-title":"Exposing the Limitations of Molecular Machine Learning with Activity Cliffs","volume":"62","author":"van Tilborg","year":"2022","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.bmc.2025.118093_b0325","doi-asserted-by":"crossref","first-page":"13408","DOI":"10.1002\/anie.201601091","article-title":"Targeted Covalent Inhibitors for Drug Design","volume":"55","author":"Baillie","year":"2016","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.bmc.2025.118093_b0330","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1039\/D1CB00085C","article-title":"19F NMR viewed through two different lenses: ligand-observed and protein-observed 19F NMR applications for fragment-based drug discovery","volume":"2","author":"Buchholz","year":"2021","journal-title":"RSC Chem Biol"},{"key":"10.1016\/j.bmc.2025.118093_b0335","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/prot.21086","article-title":"ROSETTALIGAND: protein-small molecule docking with full side-chain flexibility","volume":"65","author":"Meiler","year":"2006","journal-title":"Proteins"},{"key":"10.1016\/j.bmc.2025.118093_b0340","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/978-1-61779-465-0_10","article-title":"Rosetta Ligand docking with flexible XML protocols","volume":"819","author":"Lemmon","year":"2012","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.bmc.2025.118093_b0345","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13321-015-0095-1","article-title":"BCL:Conf: small molecule conformational sampling using a knowledge based rotamer library","volume":"7","author":"Kothiwale","year":"2015","journal-title":"J. Cheminform."},{"key":"10.1016\/j.bmc.2025.118093_b0350","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1021\/acs.jcim.0c01140","article-title":"BCL:Conf: improved open-source knowledge-based conformation sampling using the crystallography open database","volume":"61","author":"Mendenhall","year":"2021","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.bmc.2025.118093_b0355","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/B978-0-12-381270-4.00019-6","article-title":"ROSETTA3: an object-oriented software suite for the simulation and design of macromolecules","volume":"487","author":"Leaver-Fay","year":"2011","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.bmc.2025.118093_b0360","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41592-020-0848-2","article-title":"Macromolecular modeling and design in Rosetta: recent methods and frameworks","volume":"17","author":"Leman","year":"2020","journal-title":"Nat Methods"},{"key":"10.1016\/j.bmc.2025.118093_b0365","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/B978-0-12-394292-0.00006-0","article-title":"Scientific benchmarks for guiding macromolecular energy function improvement","volume":"523","author":"Leaver-Fay","year":"2013","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.bmc.2025.118093_b0370","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1021\/ct500864r","article-title":"Combined covalent-electrostatic model of hydrogen bonding improves structure prediction with Rosetta","volume":"11","author":"O'Meara","year":"2015","journal-title":"J Chem Theory Comput"},{"key":"10.1016\/j.bmc.2025.118093_b0375","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0240450","article-title":"Assessing multiple score functions in Rosetta for drug discovery","volume":"15","author":"Smith","year":"2020","journal-title":"PLoS One"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089625000343?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089625000343?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T05:23:21Z","timestamp":1740461001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089625000343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":75,"alternative-id":["S0968089625000343"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2025.118093","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification and optimization of a small molecule inhibitor of the ovarian tumor protease of the Crimean-Congo hemorrhagic fever virus","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2025.118093","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"118093"}}